Get the Stockscreener App
0.8587
2.52%
-0.0222
Azitra Inc stock is traded at $0.8587, with a volume of 172.92K.
It is down -2.52% in the last 24 hours and up +365.42% over the past month.
Azitra, Inc., a pre-clinical biopharmaceutical company, focuses on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases. It is developing ATR-12, a genetically modified strain of S. epidermidis for treating Netherton syndrome, a skin disease; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash experienced by cancer patients undergoing epidermal growth factor receptor inhibitor; and ATR-01, an engineered recombinant human filaggrin protein for treating ichthyosis vulgaris, a skin disease. The company was incorporated in 2014 and is based in Branford, Connecticut.
See More
Previous Close:
$0.8809
Open:
$0.8758
24h Volume:
172.92K
Relative Volume:
0.04
Market Cap:
$3.03M
Revenue:
$1.27M
Net Income/Loss:
$-11.28M
P/E Ratio:
-0.0383
EPS:
-22.4496
Net Cash Flow:
$-10.46M
1W Performance:
-19.75%
1M Performance:
+365.42%
6M Performance:
+151.08%
1Y Performance:
+47.26%
1-Day Range:
$0.85
$0.91
1-Week Range:
$0.85
$1.04
52-Week Range:
$0.1305
$1.40
Azitra Inc Stock (AZTR) Company Profile
Name
Azitra Inc
Sector
Industry
Phone
203 646 6446
Address
21 Business Park Drive, Branford
Compare AZTR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AZTR
Azitra Inc
|
0.8587 | 3.11M | 1.27M | -11.28M | -10.46M | -22.45 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Azitra Inc Stock (AZTR) Latest News
Price action breakdown for Azitra Inc.July 2025 Spike Watch & Weekly Chart Analysis and Trade Guides - Newser
Can swing trading help recover from Azitra Inc. lossesBull Run & Consistent Return Strategy Ideas - Newser
How moving averages guide Azitra Inc. tradingTrade Ideas & Scalable Portfolio Growth Methods - Newser
Will Azitra Inc. benefit from macro trends2025 Macro Impact & Free Daily Entry Point Trade Alerts - Newser
Is it time to cut losses on Azitra Inc.Market Movement Recap & Expert Approved Momentum Ideas - Newser
Is Azitra Inc. stock good for income investorsJuly 2025 Institutional & Target Return Focused Stock Picks - خودرو بانک
What are the future prospects of Azitra Inc.July 2025 Technicals & Free Weekly Watchlist of Top Performers - خودرو بانک
Azitra doses first patient in Phase 1/2 clinical trial of ATR04-484 - MSN
Using data tools to time your Azitra Inc. exit2025 Market WrapUp & Fast Momentum Stock Entry Tips - Newser
Azitra Inc.’s ATR04-484 Study: A Promising Step in Treating EGFRi-Associated Rash - TipRanks
Can Azitra Inc. outperform in the next rallyWeekly Trend Summary & Proven Capital Preservation Tips - خودرو بانک
Is Azitra Inc. stock a value trapJuly 2025 PostEarnings & Real-Time Chart Pattern Alerts - خودرو بانک
Promising Safety Results: Azitra's Netherton Syndrome Treatment Progress at Global Investment Conference - Stock Titan
Earnings visualization tools for Azitra Inc.Quarterly Portfolio Summary & Trade Opportunity Analysis - Newser
What moving averages say about Azitra Inc.2025 Technical Overview & Safe Entry Zone Identification - Newser
Should you wait for a breakout in Azitra Inc.July 2025 Breakouts & Verified Chart Pattern Signals - Newser
Tick level data insight on Azitra Inc. volatilityJuly 2025 Selloffs & Risk Managed Investment Strategies - Newser
Will breakout in Azitra Inc. lead to full recoveryQuarterly Trade Review & Accurate Trade Setup Notifications - Newser
Market reaction to Azitra Inc.’s recent newsJuly 2025 Catalysts & Entry and Exit Point Strategies - Newser
Backtesting results for Azitra Inc. trading strategiesMarket Sentiment Summary & Stepwise Entry/Exit Trade Alerts - Newser
Is Azitra Inc.’s ROIC above industry averageWeekly Stock Summary & AI Forecasted Stock Moves - خودرو بانک
What data driven models say about Azitra Inc.’s futureJuly 2025 Short Interest & Accurate Buy Signal Alerts - Newser
Does Azitra Inc. have a competitive edge2025 Market Overview & Safe Capital Growth Tips - خودرو بانک
Top chart patterns to watch in Azitra Inc.July 2025 Spike Watch & Weekly Setup with High ROI Potential - Newser
Analyzing Azitra Inc. with risk reward ratio chartsWeekly Market Report & Expert Curated Trade Setup Alerts - Newser
Key metrics from Azitra Inc.’s quarterly data2025 Earnings Surprises & Safe Entry Point Alerts - Newser
Using fundamentals and technicals on Azitra Inc.Stock Surge & Reliable Momentum Entry Alerts - Newser
Azitra shares surge after first patient receives ATR04-484 in Phase 1/2 trial - MSN
Azitra Inc. Approaches Support With Recovery in Sight getLinesFromResByArray error: size == 0 - 강소기업뉴스
Azitra Inc. Recovery Hinges on Volume Breakout getLinesFromResByArray error: size == 0 - thegnnews.com
Developing predictive dashboards with Azitra Inc. dataGold Moves & Precise Entry and Exit Recommendations - Newser
How to interpret RSI for Azitra Inc. stockRecession Risk & Fast Moving Stock Watchlists - Newser
Price Clustering Detected in Azitra Inc. Stock getLinesFromResByArray error: size == 0 - 강소기업뉴스
Azitra Inc Announces Reverse Stock Split Implementation - MSN
Applying Elliott Wave Theory to Azitra Inc.July 2025 Outlook & Long-Term Safe Investment Ideas - Newser
Azitra Inc Stock (AZTR) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.40%
Cap:
|
Volume (24h):